DOJ Issues Medical‑Only Schedule III Order: Caution Warranted

On April 22, 2026, the U.S. Department of Justice (DOJ), acting through the Drug Enforcement Administration (DEA), issued a Final Order rescheduling certain marijuana products from Schedule I to Schedule III under the Controlled Substances Act (CSA). The order applies only to (i) FDA approved marijuana products and (ii) marijuana held pursuant to a qualifying state medical marijuana license, while expressly leaving all other marijuana, including adult use cannabis, in Schedule I.... By: Harris Beach Murtha